[30P-pm] Drug design/Screening/adioisotopes, radiopharmaceuticals/Others

[30P-pm106S] Development of a hybrid compound of a small molecule CD4 mimic with a polyethylene glycol as an HIV entry inhibitor

○Yuki Kuroda¹, Takuya Kobayakawa¹, Kohei Tsuji¹, Kiju Konno¹, Nami Ohashi^1,2, Ami Masuda¹, Yutaro Miura¹, Takeo Kuwata³, Kazuhisa Yoshimura⁴, Tomoyuki Miura⁵, Shigeyoshi Harada⁶, Shuzo Matsushita³, Hirokazu Tamamura¹ (1. Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2. Showa Pharmaceutical University, 3. Joint Research Center for Human Retrovirus Infection, 4. Tokyo Metropolitan Institute of Public Health, 5. Institute for Frontier Life and Medical Sciences, Kyoto University, 6. AIDS Research Center, National Institute of Infectious Diseases)